Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Company News
Suratwwala Business Group Ltd
Industry : Construction
BSE Code
ISIN Demat
Book Value(
)
543218
INE05ST01028
2.037837
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
SBGLP
100.45
2125.22
EPS(TTM)
Face Value(
)
Div & Yield %:
1.22
1
0
Back
Kabra Drugs reports standalone net loss of Rs 0.11 crore in the December 2023 quarter
Feb 14,2024
Net Loss of Kabra Drugs reported to Rs 0.11 crore in the quarter ended December 2023 as against net loss of Rs 0.06 crore during the previous quarter ended December 2022. There were no Sales reported in the quarter ended December 2023 and during the previous quarter ended December 2022.